Skip to content
value.today

Pluri Inc.

Formerly PLURISTEM THERPEUTICS INC., PLURISTEM LIFE SYSTEMS INC.

Total raised
$1 M
1 round on record
Latest round
$1 M
Oct 2010
First round on record
Oct 2010
Today
Went public
See the company page

Pluri Inc. is listed today as Pluri Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 3 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Pluri Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2026$4 MPrivate placement after listing$2 to $10 million

Pluri Inc.: Private sale, Aug 2026

Investors in this round

1 investor had bought by the notice of Sep 4, 2026: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Liat Zalts · Executive Officer · Chief Financial Officer and Treasurer
  • Yaky Yanay · Executive Officer, Director · Chief Executive Officer, President and Director
  • Alexandre Weinstein · Director · Chairman of the Board of Directors
  • Doron Shorrer · Director
  • Maital Shemesh-Rasmussen · Director
  • Rami Levi · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • A.G.P/ Alliance Global Partners (CRD 000003861) · New York, New YorkSold in NY

Remarks in the notice

  • On fees: “The amounts do not include cash fees paid to A.G.P./Alliance Global Partners in connection with the concurrent registered direct offering.”
  • On the amounts: “The total offering amount reflects the total gross proceeds to be received by the Company assuming cash exercise of all warrants. The amount does not include the total gross proceeds received by the company in the concurrent registered direct offering.”

Signed by Liat Zalts, Chief Financial Officer and Treasurer. Source: SEC Form D, newest notice filed Sep 4, 2026. Read the notice at the SEC.

optionsSEC
Feb 2025$4 MPrivate placement after listing$2 to $10 million

Pluri Inc.: Private sale, Feb 2025

Investors in this round

1 investor had bought by the notice of Mar 19, 2025: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Liat Zalts · Executive Officer · Chief Financial Officer
  • Yaky Yanay · Executive Officer, Director · Chief Executive Officer, President and Director
  • Alejandro Weinstein · Director
  • Doron Birger · Director
  • Maital Shemesh-Ramussen · Director
  • Rami Levi · Director
  • Zami Aberman · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Liat Zalts, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 19, 2025. Read the notice at the SEC.

equity, optionsSEC
Dec 2022$8 MPrivate placement after listing$2 to $10 million

Pluri Inc.: Private sale, Dec 2022

Investors in this round

14 investors had bought by the notice of Dec 30, 2022: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Chen Franco-Yehuda · Executive Officer · Chief Financial Officer
  • Yaky Yanay · Executive Officer · Chief Executive Officer and President
  • Doron Birger · Director
  • Maital Shemesh-Rasmussen · Director
  • Rami Levi · Director
  • Varda Shalev · Director
  • Zami Aberman · Director · Chairman of the Board of Directors

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Chen Franco-Yehuda, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 30, 2022. Read the notice at the SEC.

equity, optionsSEC
Oct 2010$1 MNo. 1Under $2 million

Pluri Inc.: Raise no. 1, Oct 2010

Investors in this round

9 investors had bought by the notice of Oct 14, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$55,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Yaky Yanay · Executive Officer
  • Zami Aberman · Executive Officer, Director
  • Doron Shorrer · Director
  • Hava Meretzki · Director
  • Isaac Braun · Director
  • Israel Ben-Yoram · Director
  • Mark Germain · Director
  • Nachum Rosman · Director
  • Shai Pines · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Rodman & Renshaw, LLC (CRD 16415) · New York, New YorkSold in CA, GA, IL, MA, NY

Remarks in the notice

  • On fees: “In addition, Rodman & Renshaw, LLC received(i)45,833 warrants to purchase sharesof the company at $1.80 per share; and (ii) reimbursement of expenses of up to $2,000.”
  • On a merger: “Item 11 Note: No minimum investment.”

Signed by Yaky Yanay, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 14, 2010. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pluri Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2026).

    SEC Form D · Sep 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Sep 2026

That is all the official record says: Pluri Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Pluri Inc. are on record.

Investors#

No investor of Pluri Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 9 investors.

Largest shareholders today

Institutions holding Pluri Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pluri Inc.
NameRoleNamed in
Liat ZaltsChief Financial Officer and TreasurerSep 2026
Yaky YanayChief Executive Officer, President and DirectorSep 2026
Chen Franco-YehudaChief Financial OfficerDec 2022
Zami AbermanExecutive officerOct 2010
Alexandre WeinsteinChairman of the Board of DirectorsSep 2026
Doron ShorrerDirectorSep 2026
Maital Shemesh-RasmussenDirectorSep 2026
Rami LeviDirectorSep 2026
Yaky YanayChief Executive Officer, President and DirectorSep 2026
Alejandro WeinsteinDirectorMar 2025
Doron BirgerDirectorMar 2025
Maital Shemesh-RamussenDirectorMar 2025
Zami AbermanChairman of the Board of DirectorsMar 2025
Varda ShalevDirectorDec 2022
Hava MeretzkiDirectorOct 2010
Isaac BraunDirectorOct 2010
Israel Ben-YoramDirectorOct 2010
Mark GermainDirectorOct 2010
Nachum RosmanDirectorOct 2010
Shai PinesDirectorOct 2010

About

Israeli company engaged in the development of human placental adherent stromal cells for commercial use.

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.